Terns Pharmaceuticals Inc. (TERN) NASDAQ
$4.59 0.05 (1.10%)
Market Cap: $293.52M
As of 04/18/24 04:00 PM EDT. Market closed.
Terns Pharmaceuticals Inc. (TERN)
NASDAQ
$4.59
0.05 (1.10%)
Market Cap: $293.52M
As of 04/18/24 04:00 PM EDT. Market closed.
terns pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver diseases and cancers. the company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in china to advance its growing pipeline of ... read more
terns pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver diseases and cancers. the company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in china to advance its growing pipeline of drugs that are optimized against clinically-validated targets. based in san mateo, california and shanghai, terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in china and globally. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Vivo Opportunity, LLC | 10% Owner | Apr 02, 2024 | Sale | $6.65 | 22,084 | 146,859 | 1,975,062 | Apr 03, 2024, 08:47 PM |
Vivo Opportunity, LLC | 10% Owner | Apr 02, 2024 | Sale | $6.65 | 76,346 | 507,701 | 4,127,611 | Apr 03, 2024, 08:47 PM |
Vivo Opportunity, LLC | 10% Owner | Apr 01, 2024 | Sale | $6.99 | 5,451 | 38,102 | 275,772 | Apr 03, 2024, 08:47 PM |
Vivo Opportunity, LLC | 10% Owner | Apr 03, 2024 | Sale | $6.20 | 4,149 | 25,724 | 268,573 | Apr 03, 2024, 08:47 PM |
Vivo Opportunity, LLC | 10% Owner | Apr 01, 2024 | Sale | $6.99 | 39,411 | 275,483 | 1,997,146 | Apr 03, 2024, 08:47 PM |
Vivo Opportunity, LLC | 10% Owner | Apr 03, 2024 | Sale | $6.20 | 30,047 | 186,291 | 1,945,015 | Apr 03, 2024, 08:47 PM |
Vivo Opportunity, LLC | 10% Owner | Apr 01, 2024 | Sale | $6.99 | 136,255 | 952,422 | 4,203,957 | Apr 03, 2024, 08:47 PM |
Vivo Opportunity, LLC | 10% Owner | Apr 03, 2024 | Sale | $6.20 | 103,870 | 643,994 | 4,023,741 | Apr 03, 2024, 08:47 PM |
Vivo Opportunity, LLC | 10% Owner | Apr 02, 2024 | Sale | $6.65 | 3,050 | 20,283 | 272,722 | Apr 03, 2024, 08:47 PM |
Yoon Seokho Bryan | COO and General Counsel | Nov 30, 2023 | Buy | $3.78 | 743 | 2,809 | 18,399 | Dec 04, 2023, 06:03 PM |
Vignola Mark J. | Chief Financial Officer | Nov 30, 2023 | Buy | $3.78 | 743 | 2,809 | 18,399 | Dec 04, 2023, 06:03 PM |
Vignola Mark J. | Chief Financial Officer | May 31, 2023 | Buy | $1.41 | 9,997 | 14,096 | 17,656 | Jun 02, 2023, 05:03 PM |
Yoon Seokho Bryan | COO and General Counsel | May 31, 2023 | Buy | $1.41 | 9,997 | 14,096 | 17,656 | Jun 02, 2023, 05:03 PM |
Sundaram Senthil Vel | Chief Executive Officer | May 31, 2023 | Buy | $1.41 | 2,111 | 2,977 | 9,770 | Jun 02, 2023, 05:03 PM |
Yoon Seokho Bryan | COO and General Counsel | Nov 30, 2022 | Buy | $1.41 | 3 | 4 | 7,659 | Feb 03, 2023, 06:01 PM |
Vignola Mark J. | Chief Financial Officer | Nov 30, 2022 | Buy | $1.41 | 3 | 4 | 7,659 | Feb 03, 2023, 06:01 PM |
Sundaram Senthil Vel | Chief Executive Officer | Nov 30, 2022 | Buy | $1.41 | 3 | 4 | 7,659 | Feb 03, 2023, 06:00 PM |
ORBIMED ADVISORS LLC | Director | Dec 23, 2022 | Buy | $7.25 | 137,931 | 1,000,000 | 4,882,854 | Dec 28, 2022, 05:57 PM |
GORDON CARL L | Director | Dec 23, 2022 | Buy | $7.25 | 137,931 | 1,000,000 | 4,882,854 | Dec 28, 2022, 05:46 PM |
Vivo Opportunity, LLC | 10% Owner | Dec 23, 2022 | Buy | $7.25 | 758,620 | 5,499,995 | 4,340,212 | Dec 23, 2022, 05:48 PM |
Lu Hongbo | Director | Dec 23, 2022 | Buy | $7.25 | 758,620 | 5,499,995 | 4,340,212 | Dec 23, 2022, 05:44 PM |
LAV Biosciences Fund V, L.P. | 10% Owner | Nov 23, 2022 | Sale | $5.50 | 1,500,000 | 8,250,000 | 1,059,523 | Nov 28, 2022, 04:56 PM |
Vivo Opportunity, LLC | 10% Owner | Sep 07, 2022 | Buy | $3.60 | 600,000 | 2,160,000 | 3,581,592 | Sep 08, 2022, 08:00 PM |
Lu Hongbo | Director | Sep 07, 2022 | Buy | $3.60 | 600,000 | 2,160,000 | 3,581,592 | Sep 08, 2022, 08:00 PM |
ORBIMED ADVISORS LLC | Director | Aug 16, 2022 | Buy | $2.42 | 3,690,000 | 8,929,800 | 4,744,923 | Aug 18, 2022, 05:00 PM |
GORDON CARL L | Director | Aug 16, 2022 | Buy | $2.42 | 3,690,000 | 8,929,800 | 4,744,923 | Aug 18, 2022, 04:50 PM |
Vivo Opportunity, LLC | 10% Owner | Aug 16, 2022 | Buy | $2.42 | 1,500,000 | 3,630,000 | 2,981,592 | Aug 16, 2022, 08:44 PM |
Vivo Opportunity, LLC | 10% Owner | Aug 15, 2022 | Buy | $2.99 | 1,218 | 3,642 | 1,481,592 | Aug 16, 2022, 08:44 PM |
Vivo Opportunity, LLC | 10% Owner | Aug 12, 2022 | Buy | $2.98 | 1,123,021 | 3,346,603 | 1,480,374 | Aug 16, 2022, 08:44 PM |
Lu Hongbo | Director | Aug 15, 2022 | Buy | $2.99 | 1,218 | 3,642 | 1,481,592 | Aug 16, 2022, 08:30 PM |
Lu Hongbo | Director | Aug 12, 2022 | Buy | $2.98 | 1,123,021 | 3,346,603 | 1,480,374 | Aug 16, 2022, 08:30 PM |
Lu Hongbo | Director | Aug 16, 2022 | Buy | $2.42 | 1,500,000 | 3,630,000 | 2,981,592 | Aug 16, 2022, 08:30 PM |
Yoon Seokho Bryan | COO and General Counsel | May 31, 2022 | Buy | $1.47 | 7,656 | 11,254 | 7,656 | Jun 08, 2022, 09:28 PM |
Vignola Mark J. | Chief Financial Officer | May 31, 2022 | Buy | $1.47 | 7,656 | 11,254 | 7,656 | Jun 08, 2022, 09:27 PM |
Sundaram Senthil Vel | Chief Executive Officer | May 31, 2022 | Buy | $1.47 | 7,656 | 11,254 | 7,656 | Jun 08, 2022, 09:27 PM |
GORDON CARL L | Director | Feb 09, 2021 | Buy | $17.00 | 475,000 | 8,075,000 | 2,274,723 | Feb 09, 2021, 03:10 PM |
ORBIMED ADVISORS LLC | Director | Feb 09, 2021 | Buy | $17.00 | 475,000 | 8,075,000 | 2,274,723 | Feb 09, 2021, 03:09 PM |
Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Buy | $17.00 | 357,353 | 6,075,001 | 357,353 | Feb 09, 2021, 03:08 PM |
Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Buy | $17.00 | 14,275 | 242,675 | 281,223 | Feb 09, 2021, 03:08 PM |
Vivo Capital VIII, LLC | 10% Owner | Feb 09, 2021 | Buy | $17.00 | 103,372 | 1,757,324 | 2,036,557 | Feb 09, 2021, 03:08 PM |
Flynn James E | 10% Owner | Feb 09, 2021 | Buy | $17.00 | 665,000 | 11,305,000 | 2,382,033 | Feb 09, 2021, 02:55 PM |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ORBIMED ADVISORS LLC | 7,619,135 | 0.99% | No change | Other |
VIVO CAPITAL, LLC | 6,657,992 | 3.54% | No change | Other |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,837,126 | 1.71% | -3.39% | Growth At A Reasonable Price |
BLACKROCK INC. | 3,408,978 | 0.00056% | 7.71% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 1,130,052 | 0.09% | -30.15% | Growth |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,050,000 | 0.01% | 950% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 840,459 | 0.00057% | 6.64% | Other |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 17,290 | 0.00207% | New | Other |
BALYASNY ASSET MANAGEMENT L.P. | 13,854 | 0.00017% | New | Event Driven |
Period of Report: 12/31/2023
10-K/10-Q Filings: View